The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study.
Beverley BalkauBernard CharbonnelAlfred PenfornisNora ChraibiAmir LahouegueCéline FaureFlorence Thomas-DelecourtBruno DetournayPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)
AstraZeneca, France.
Keyphrases